306 related articles for article (PubMed ID: 21407077)
1. Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study.
Mazzone A; Parri MS; Giannessi D; Ravani M; Vaghetti M; Altieri P; Casalino L; Maltinti M; Balbi M; Barsotti A; Berti S
Coron Artery Dis; 2011 May; 22(3):179-87. PubMed ID: 21407077
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
Pelliccia F; Cianfrocca C; Rosano G; Mercuro G; Speciale G; Pasceri V
JACC Cardiovasc Interv; 2010 Jan; 3(1):78-86. PubMed ID: 20129574
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
6. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
7. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
Saleh N; Tornvall P
Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
[TBL] [Abstract][Full Text] [Related]
8. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis.
Niccoli G; Ferrante G; Cosentino N; Conte M; Belloni F; Marino M; Bacà M; Montone RA; Sabato V; Schiavino D; Patriarca G; Crea F
Atherosclerosis; 2010 Aug; 211(2):606-11. PubMed ID: 20307883
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.
Kato R; Momiyama Y; Ohmori R; Tanaka N; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
Circ J; 2009 Jan; 73(1):152-7. PubMed ID: 19023151
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
14. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
[TBL] [Abstract][Full Text] [Related]
15. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes.
Lee SY; Mintz GS; Kim SY; Hong YJ; Kim SW; Okabe T; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
JACC Cardiovasc Interv; 2009 Jan; 2(1):65-72. PubMed ID: 19463400
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
Hognestad A; Endresen K; Wergeland R; Mellembakken JR; Mollnes TE; Omland T; Kjekshus JK; Aukrust P; Andreassen AK
J Heart Lung Transplant; 2005 Aug; 24(8):1026-32. PubMed ID: 16102437
[TBL] [Abstract][Full Text] [Related]
17. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention.
Liu PY; Li YH; Tsai WC; Chao TH; Tsai LM; Wu HL; Chen JH
Eur Heart J; 2003 Oct; 24(20):1824-32. PubMed ID: 14563341
[TBL] [Abstract][Full Text] [Related]
19. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting.
Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2011 Oct; 124(19):3022-9. PubMed ID: 22040548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
